{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:14:59Z","timestamp":1790435699351,"version":"4.1.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>At the time of diagnosis, systemic sclerosis (SSc) is often well established with significant irreversible tissue and organ damage. Definitions of \u2018early SSc\u2019 have been proposed, which include the presence of SSc-associated autoantibodies. In addition, functional autoantibodies that are believed to be involved in SSc pathogenesis need to be considered. In this review, recent advances in the diagnostic utility and pathogenic role of autoantibodies in early SSc are summarized. Moreover, we propose a clinical care pathway illustrating how autoantibody testing along with key clinical features can be used to make an earlier diagnosis of SSc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Recent evidence has helped to develop a clearer understanding of the natural history, early clinical features, and autoantibodies that are predictors of SSc. The role of functional autoantibodies is leading to innovative approaches to evidence-based interventions and therapies that are based on mechanisms of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Despite substantial advances, the high morbidity and mortality that currently characterizes SSc can largely be attributed to a delay in diagnosis, gaps in our understanding of the role of autoantibodies in early disease, and limited effective therapeutic options. An early and accurate diagnosis of SSc and use of autoantibody testing embedded in evidence-based clinical care pathways will help improve SSc-associated clinical outcomes and healthcare expenditures.<\/jats:p><\/jats:sec>","DOI":"10.1097\/bor.0000000000000325","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T18:25:00Z","timestamp":1467915900000},"page":"586-594","source":"Crossref","is-referenced-by-count":32,"title":["Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis"],"prefix":"10.1097","volume":"28","author":[{"given":"May Y.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2015.00167","article-title":"Autoantibodies in systemic sclerosis: unanswered questions","volume":"6","author":"Kayser","year":"2015","journal-title":"Front Immunol"},{"key":"R4-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/art.39727","article-title":"Are autoantibodies involved in the pathogenesis of systemic sclerosis?","author":"Fritzler","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-015-0517-1","article-title":"The immunopathology of systemic sclerosis","volume":"37","author":"van Laar","year":"2015","journal-title":"Semin Immunopathol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-015-0505-4","article-title":"Functional autoantibodies in systemic sclerosis pathogenesis","volume":"17","author":"Kill","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10067-015-2902-5","article-title":"Early systemic sclerosis-opportunities for treatment","volume":"34","author":"Sakkas","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","article-title":"Quality of life in systemic sclerosis","volume":"14","author":"Almeida","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.24086","article-title":"The cost of systemic sclerosis","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3899\/jrheum.120600","article-title":"Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population","volume":"39","author":"Furst","year":"2012","journal-title":"J Rheumatol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/acr.22167","article-title":"Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain","volume":"66","author":"Lopez-Bastida","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/03009742.2014.976653","article-title":"The economic burden and health-related quality of life associated with systemic sclerosis in France","volume":"44","author":"Chevreul","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48","author":"Mosca","year":"2014","journal-title":"J Autoimmun"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/art.1780380216","article-title":"HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients","volume":"38","author":"Gendi","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis: a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/RHU.0000000000000232","article-title":"Systemic sclerosis: commonly asked questions by rheumatologists","volume":"21","author":"Young","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","article-title":"Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014","volume":"27","author":"Young","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"R22-20230829","first-page":"754","article-title":"Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis","volume":"25","author":"Hudson","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification Criteria for Systemic Sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R24-20230829","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/art.22364","article-title":"Revising the classification criteria for systemic sclerosis","volume":"55","author":"Nadashkevich","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R27-20230829","first-page":"141","article-title":"A new way of thinking about systemic sclerosis: the opportunity for a very early diagnosis","volume":"18","author":"Guiducci","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2014.11.002","article-title":"Undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc)","volume":"14","author":"Valentini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/acr.22304","article-title":"Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both","volume":"66","author":"Valentini","year":"2014","journal-title":"Arthritis Care Res(Hoboken)"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ard.2008.106302","article-title":"The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy","volume":"68","author":"Matucci-Cerinic","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis","volume":"54","author":"Bruni","year":"2015","journal-title":"Rheumatology(Oxford)"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2011-201072","article-title":"Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis","volume":"72","author":"Barskova","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2013-203889","article-title":"Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS\/EUSTAR centre","volume":"74","author":"Lepri","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","first-page":"313","article-title":"Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD)","volume":"21","author":"Bodolay","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","article-title":"Mixed connective tissue disease: a subsequent evaluation of the original twenty-five patients","volume":"59","author":"Nimelstein","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","article-title":"To be or not to be,\u2019 ten years after: evidence for mixed connective tissue disease as a distinct entity","volume":"41","author":"Cappelli","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13317-012-0030-7","article-title":"Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent","volume":"3","author":"Fritzler","year":"2012","journal-title":"Auto Immun Highlights"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"(Suppl 91)","key":"R43-20230829","first-page":"131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"415272","DOI":"10.5402\/2012\/415272","article-title":"Anti-Ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma","volume":"2012","author":"Ferreira","year":"2012","journal-title":"ISRN Rheumatol"},{"key":"R46-20230829","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.04.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","author":"Wallukat","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780340111","article-title":"Prognostic significance of anticentromere antibodies and antitopoisomerase I antibodies in Raynaud's disease: a prospective study","volume":"34","author":"Weiner","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4236","article-title":"Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers","volume":"15","author":"Valentini","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/sji.12335","article-title":"The role of cell death in the pathogenesis of SLE: is pyroptosis the missing link?","volume":"82","author":"Magna","year":"2015","journal-title":"Scand J Immunol"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","article-title":"Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE","volume":"7","author":"Mahajan","year":"2016","journal-title":"Front Immunol"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"e0130575","DOI":"10.1371\/journal.pone.0130575","article-title":"Physical features of intracellular proteins that moonlight on the cell surface","volume":"10","author":"Amblee","year":"2015","journal-title":"PLoS One"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.00181410","article-title":"Targets of antiendothelial cell antibodies in pulmonary hypertension and scleroderma","volume":"39","author":"Dib","year":"2012","journal-title":"Eur Respir J"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Antiendothelial cell antibodies in systemic sclerosis","volume":"69","author":"Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0394632015572750","article-title":"From microvasculature to fibroblasts: contribution of antiendothelial cell antibodies in systemic sclerosis","volume":"28","author":"Corallo","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/rheumatology\/kem241","article-title":"Antifibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts","volume":"46","author":"Fineschi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"Fineschi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F","article-title":"Autoantibodies to fibrillin 1 in systemic sclerosis","volume":"43","author":"Tan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"R1221","DOI":"10.1186\/ar1813","article-title":"Absence of autoantibodies against correctly folded recombinant fibrillin-1 protein in systemic sclerosis patients","volume":"7","author":"Brinckmann","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","article-title":"Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis","volume":"120","author":"Sato","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","article-title":"Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis","volume":"138","author":"Nishijima","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/ard.2007.085480","article-title":"Anti-PDGFR-alpha antibodies measured by nonbioactivity assays are not specific of systemic sclerosis","volume":"67","author":"Balada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R64-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/art.39728","article-title":"Induction of scleroderma fibrosis in skin-humanized mice by anti-platelet-derived growth factor receptor agonistic autoantibodies","author":"Luchetti","year":"2016","journal-title":"Arthritis Rheum"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.39125","article-title":"Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor alpha autoantibodies in systemic sclerosis","volume":"67","author":"Moroncini","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3899\/jrheum.150474","article-title":"Monocytic angiotensin and endothelin receptor imbalance modulate secretion of the profibrotic chemokine ligand 18","volume":"43","author":"Rademacher","year":"2016","journal-title":"J Rheumatol"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.39558","article-title":"Anti-interferon-inducible protein 16 antibodies associate with digital gangrene in patients with scleroderma","volume":"68","author":"McMahan","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R68-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/art.39743","article-title":"Autoantigens targeted in scleroderma patients with vascular disease are enriched in endothelial lineage cells","author":"McMahan","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R69-20230829","first-page":"1643","article-title":"The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma)","volume":"32","author":"Sen\u00e9cal","year":"2005","journal-title":"J Rheumatol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-8-31","article-title":"What is a clinical pathway? Development of a definition to inform the debate","volume":"8","author":"Kinsman","year":"2010","journal-title":"BMC Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:18:58Z","timestamp":1718684338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201611000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000325","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}